Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Baseline details and univariate associations with GDF-15 levels (n = 146) [11] Factor | Baseline level | Correlation versus log10GDF-15 | p for correlation | | | Mean log10GDF-15Present versus absent | p for comparison: 25OHD (nmol/L) (SD) | 44 (15) | −0.11 | 0.17
Source: Results table. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Randomised controlled trial.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
We conducted analyses using samples and data collected prospectively as part of the vitamin D in isolated systolic hypertension (VitDISH) randomised controlled trial, which tested the effect of vitamin D supplementation on blood pressure in patients aged 70 and over with isolated systolic hypertension [].
Source: Methods.
We conducted analyses using samples and data collected prospectively as part of the vitamin D in isolated systolic hypertension (VitDISH) randomised controlled trial, which tested the effect of vitamin D supplementation on blood pressure in patients aged 70 and over with isolated systolic hypertension [].
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Association between GDF-15 levels and changes in vascular and physical function in older patients with hypertension
Randomised controlled trial · Aging Clinical and Experimental Research · 2016
Original publication title
Association between GDF-15 levels and changes in vascular and physical function in older patients with hypertension
© The Author(s) 2016
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
To correlate baseline GDF-15 levels with physical and vascular health data in this population.
Source: AimsAbstract: What methods does the paper describe?
Baseline blood samples were analysed using a GDF-15 ELISA assay kit. Correlations with baseline and 12-month outcome data, including measures of physical and vascular function, were performed.
Source: MethodsAbstract: Results
A total of 147 individuals, mean age 76.8 ± 4.7 years, were included. 77 (52 %) were male. Baseline log10GDF-15 showed significant correlations with age (r = 0.37, p < 0.001), total cholesterol (r = −0.33, p < 0.001) and 6-min walking distance (r = −0.37, p < 0.001). Age remained significantly associated with log10GDF-15 in multivariable analysis (beta = −0.29, p = 0.001). Baseline log10GDF-15 was significantly associated with decline in 6-min walk distance over 12 months (beta = −0.27, p = 0.01) in multivariable models.
No significant correlations were seen with changes in vascular function over 12 months.
Source: ResultsAbstract: Conclusion
Baseline GDF-15 predicts declining physical, but not vascular, function in our population.
Source: ConclusionAuthors’ abstract
Background
Growth differentiation factor-15 (GDF-15) may be a biomarker of disease, protective response and/or prognosis, in older people with hypertension.
Aims
To correlate baseline GDF-15 levels with physical and vascular health data in this population.
Methods
Baseline blood samples were analysed using a GDF-15 ELISA assay kit. Correlations with baseline and 12-month outcome data, including measures of physical and vascular function, were performed.
Results
A total of 147 individuals, mean age 76.8 ± 4.7 years, were included. 77 (52 %) were male. Baseline log10GDF-15 showed significant correlations with age (r = 0.37, p < 0.001), total cholesterol (r = −0.33, p < 0.001) and 6-min walking distance (r = −0.37, p < 0.001). Age remained significantly associated with log10GDF-15 in multivariable analysis (beta = −0.29, p = 0.001). Baseline log10GDF-15 was significantly associated with decline in 6-min walk distance over 12 months (beta = −0.27, p = 0.01) in multivariable models.
No significant correlations were seen with changes in vascular function over 12 months.
Conclusion
Baseline GDF-15 predicts declining physical, but not vascular, function in our population.
Publication and source details
Original title: Association between GDF-15 levels and changes in vascular and physical function in older patients with hypertension
Maryam Barma; Faisel Khan; Rosemary J. G. Price; Peter T. Donnan; C. Martina Messow; Ian Ford; Alex McConnachie; Allan D. Struthers; Marion E. T. McMurdo; Miles D. Witham
Aging Clinical and Experimental Research · 2016
© The Author(s) 2016https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.http://dx.doi.org/10.13039/501100000589Chief Scientist OfficeCZH/4/1100Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-12T19:57:13.323065+00:00
DOI: 10.1007/s40520-016-0636-0 · PMC5589783